PTCT Forecast



Price Forecast:


Bearish<—>Bullish



80% Confidence




Bullish Case: Positive data from Vatiquinone trials could spur FDA approval, potentially leading to a >40% price increase. Additionally, strategic royalty monetization provides liquidity to sustain operations.




Bearish Case: Continued high volatility (90% IV) indicates market uncertainty. Regulatory setbacks or further operational cuts could lead to a significant price drop, exacerbating investor fears.




Potential Outcomes:
  • 60% success in Vatiquinone approval - bullish price action.
  • 30% workforce cuts impacting R&D negatively - potential price decline by 50%.
  • 10% legal investigations harming reputation - could drop price by 30%.




Trading Oracle: Expect high implied volatility to persist. Engage in bullish long call spreads, particularly between $45 and $50 strikes. This strategy capitalizes on anticipated price movements from Vatiquinone outcomes while managing risk effectively with a focus on 3-4 month horizons.



December 18, 2024


PTC Therapeutics Forecast

PTCT        PTC Therapeutics











Correlated Assets

Assets that tend to move strongly with PTCT



CRK Forecast + Options Trading Strategies   CRK  Comstock Resources (0.91)


ONON Forecast + Options Trading Strategies   ONON  On (0.9)


HOOD Forecast + Options Trading Strategies   HOOD  Robinhood Markets (0.89)


NRG Forecast + Options Trading Strategies   NRG  NRG Energy (0.89)


TTD Forecast + Options Trading Strategies   TTD  Trade Desk (0.89)



Uncorrelated Assets

Assets with little price relationship to PTCT



GSG Forecast + Options Trading Strategies   GSG  BlackRock Institutional Trust Company N.A. - iShares S&P GSCI Commodity-Indexed (-0.01)


LTPZ Forecast + Options Trading Strategies   LTPZ  PIMCO 15+ Year U.S. TIPS Index Exchange-Traded (0.01)


NSSC Forecast + Options Trading Strategies   NSSC  NAPCO Security (-0.02)


INTU Forecast + Options Trading Strategies   INTU  Intuit (0.02)


UWMC Forecast + Options Trading Strategies   UWMC  UWM Holdings Corporation (-0.02)



Anticorrelated Assets

Assets that tend to move strongly against PTCT



AMN Forecast + Options Trading Strategies   AMN  AMN Healthcare Services (-0.81)


XRAY Forecast + Options Trading Strategies   XRAY  DENTSPLY Sirona (-0.81)


APLS Forecast + Options Trading Strategies   APLS  Apellis Pharmaceuticals (-0.82)


CYTK Forecast + Options Trading Strategies   CYTK  Cytokinetics (-0.85)


SPXS Forecast + Options Trading Strategies   SPXS  Direxion Daily S&P 500 Bear 3X Shares (-0.88)


PTCT News over Time





Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.










Become a more profitable investor with AI optimized trading strategies






×

Chat with PTCT


 Ask any question about PTCT!